Acasti Pharma (GRCE) Revenue (2019 - 2026)
Acasti Pharma (GRCE) revenue from Jun 30, 2019 to Mar 31, 2026. The TTM Acasti Pharma (GRCE) revenue is $0. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Annual Revenue change of Acasti Pharma (GRCE)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $0 | N/A |
| 2025 | $0 | N/A |
| 2024 | $0 | N/A |
| 2023 | $0 | N/A |
| 2022 | $0 | -100.00% |
| 2021 | $200K | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |
| 2016 | $0 | N/A |